Salivary Immunoglobulin A (sIgA) Normal Range Study
NCT06248788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47
Last updated 2024-02-08
Summary
Salivary Immunoglobulin A (sIgA) is a marker of immune system activity. Typically, sIgA is determined by an ELISA test in which samples have to be sent to a specialized laboratory for testing. Investigators have developed a new instrument that is small, portable, and easy to use. This instrument is available for consumers to purchase and test their own sIgA at home.
Conditions
- Salivary Immunity
Interventions
- DEVICE
-
PoC Device
PoC Device for Testing Salivary IgA
Sponsors & Collaborators
-
4Life Research, LLC
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-06-19
- Primary Completion
- 2018-01-20
- Completion
- 2018-01-20
Countries
- United States
Study Locations
More Related Trials
-
Autoimmune Hepatitis Study
NCT00286663 ·Status: TERMINATED
-
Descriptive Study of Variations in Serum Translocation Markers of the Intestinal Microbiota in Patients With Gougerot-Sjögren Syndrome According to Disease Activity
NCT04462601 ·Status: ACTIVE_NOT_RECRUITING
-
SARS-CoV-2 IgG and IgM Serologic Assays
NCT04562246 ·Status: COMPLETED
-
Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
NCT07062523 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Wellderly Immune Antibodies Study, a Sub-Study of Healthy Elderly Active Longevity (HEAL) Cohort
NCT01816880 ·Status: COMPLETED
-
Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers
NCT07120269 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PredIcting SterOid DepeNdEnt LivEr InjuRy with Polyreactive Immunoglobulin G
NCT05810480 ·Status: RECRUITING
-
Autoimmune Protocol Diet Intervention on Proteinuria in IgA Nephropathy Patients
NCT07022574 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Immunological Measurement of Aspartate/Alanine Aminotransferase
NCT03562585 ·Status: COMPLETED
-
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
NCT06587828 ·Status: RECRUITING
-
Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients
NCT07003451 ·Status: NOT_YET_RECRUITING
-
Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy
NCT02526966 ·Status: COMPLETED ·Phase: NA
-
Sjögren and Gynecologic Considerations
NCT05670535 ·Status: COMPLETED
-
The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases
NCT06054373 ·Status: RECRUITING
-
Specific Autoantibody Testing in Patients With Interstitial Lung Disease
NCT01600352 ·Status: COMPLETED
-
Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)
NCT05131594 ·Status: ENROLLING_BY_INVITATION
-
Study of the IgA Repertoire During IgA Deposition Nephropathy.
NCT04092491 ·Status: UNKNOWN
-
Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population
NCT04568850 ·Status: UNKNOWN
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED
-
COVID-19 IgG Formation in Physicians at ALGH and Their Household Members
NCT04540484 ·Status: COMPLETED
-
Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
NCT04800731 ·Status: COMPLETED
-
Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
NCT00001257 ·Status: TERMINATED
-
Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis
NCT05473403 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Swiss Autoimmune Hepatitis Cohort Study
NCT03146884 ·Status: RECRUITING
-
COVID-19 IgG Antibodies in the Serum of Recovered Patients
NCT04470414 ·Status: UNKNOWN